Search
for
Sort by
Research 511–540 of 1000+
- Concomitant immobilization of androgen receptors and 5α- reductase in androgenic alopecia
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- 5α-Reduced glucocorticoids: a story of natural selection
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- STABILITY-INDICATING MICELLAR ELEKTROKINETIC CHROMATOGRAPHY METHOD FOR DETERMINATION OF FINASTERIDE IN PHARMACEUTICAL PREPARATIONS
- Hormones
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Hair in health and disease: an introduction
- Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)
- Androgen receptor gene polymorphism and biological age markers in men
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- The therapeutic use of androgens in women
- Associations between transition‐specific stress experience, nocturnal decline in ambulatory blood pressure, and C‐reactive protein levels among transgender men
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model
- Hormone therapy in acne
- Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne
- Chapter 17. Selective androgen receptor modulators (SARMs)
- PCOS: update and diagnostic approach